Table 2.
Patient-reported outcome | Day | Average scorea | P value compared to baseline (day 0) |
---|---|---|---|
DLQI | Day 0 | 16.3 | |
Day 3 | 10.5 | <.001* | |
Day 7 | 7.7 | <.001* | |
Day 14 | 8.6 | <.001* | |
HS pain | Day 0 | 6.4 | |
Day 3 | 3.2 | <.001* | |
Day 7 | 2.2 | <.001* | |
Day 14 | 3.1 | <.001* | |
PGI-S | Day 0 | 5.5 | |
Day 3 | 3.7 | <.001* | |
Day 7 | 3.1 | <.001* | |
Day 14 | 3.5 | <.001* | |
PGI-C |
Day 3
n (%) |
Day 7
n (%) |
Day 14
n (%) |
Very much improved | 5 (15.2) | 13 (41.9) | 12 (38.7) |
Much improved | 10 (30.3) | 12 (38.7) | 13 (41.9) |
Minimally improved | 15 (45.5) | 6 (19.4) | 5 (16.1) |
No change | 2 (6.1) | 0 (0) | 1 (3.2) |
A little worse | 1 (3.0) | 0 (0) | 0 (0) |
Much worse | 0 (0) | 0 (0) | 0 (0) |
Very much worse | 0 (0) | 0 (0) | 0 (0) |
Total number of patients | 33 | 31 | 31 |
DLQI, Dermatology Life Quality Index; HS, hidradenitis suppurativa; PGI-C, patient-global-impression-of-change; PGI-S, patient-global-impression-of-severity.
Missing data points for a specific day were kept blank and data was not filled in.
P value was determined using paired t tests. Statistically significant value at 95% confidence level.